Cell-mimicking nanolipogel for encapsulation & delivery of SPARC siRNA

The advancement in the biomedical arena witnessed various effective therapeutic agents being developed to combat various diseases. In recent years, nucleic acid agents have attracted attention as the next generation therapeutics. The driving force for using RNA interference (RNAi) as an alternative...

Full description

Saved in:
Bibliographic Details
Main Author: Muhammad Aminuddin Anuar
Other Authors: Subbu S. Venkatraman
Format: Final Year Project
Language:English
Published: 2019
Subjects:
Online Access:http://hdl.handle.net/10356/76737
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Nanyang Technological University
Language: English
id sg-ntu-dr.10356-76737
record_format dspace
spelling sg-ntu-dr.10356-767372023-03-04T15:34:31Z Cell-mimicking nanolipogel for encapsulation & delivery of SPARC siRNA Muhammad Aminuddin Anuar Subbu S. Venkatraman School of Materials Science and Engineering DRNTU::Engineering::Materials The advancement in the biomedical arena witnessed various effective therapeutic agents being developed to combat various diseases. In recent years, nucleic acid agents have attracted attention as the next generation therapeutics. The driving force for using RNA interference (RNAi) as an alternative therapy is due to its highly selective targeting through base-pair interactions, unrestricted choice of targets, minimal side effects and costeffectiveness compared to protein therapies. However, this technology has its own limitations. To overcome its drawbacks, an effective drug delivery system is needed to deliver the administered therapeutic to its intended site. In this study, cross-linked nanolipogel (NLG) particles containing Chitosan Methacrylate Anhydride (Chitosan-MA) and SPARC small interfering RNA (siRNA) were designed and fabricated in the effort to prolong the administered therapy. The formulated NLG particles were characterised and found to be spherical with diameter of 139.6 ± 0.76 nm. Following that, siRNA release study was conducted on the NLG over 28 days. From the release study, it was observed that the cross-linked NLG particle could sustain release siRNA over 28 days. The remaining SPARC siRNA within the NLG suggested potential release profile to be more than 28 days. A 14-day cell toxicity study conducted showed 0.03125mM NLG to be the suitable dosage for subsequent in vitro studies. Qualitative and quantitative cell studies conducted to observe NLG entry into Human FibroGRO fibroblast cells showed 20 % cell entry after 1-day of NLG treatment. This study validated that the NLG system developed could not only efficiently encapsulate siRNA, but also sustains release siRNA over 28 days without drastically hindering cell proliferation. Bachelor of Engineering (Materials Engineering) 2019-04-08T06:56:45Z 2019-04-08T06:56:45Z 2019 Final Year Project (FYP) http://hdl.handle.net/10356/76737 en Nanyang Technological University 52 p. application/pdf
institution Nanyang Technological University
building NTU Library
continent Asia
country Singapore
Singapore
content_provider NTU Library
collection DR-NTU
language English
topic DRNTU::Engineering::Materials
spellingShingle DRNTU::Engineering::Materials
Muhammad Aminuddin Anuar
Cell-mimicking nanolipogel for encapsulation & delivery of SPARC siRNA
description The advancement in the biomedical arena witnessed various effective therapeutic agents being developed to combat various diseases. In recent years, nucleic acid agents have attracted attention as the next generation therapeutics. The driving force for using RNA interference (RNAi) as an alternative therapy is due to its highly selective targeting through base-pair interactions, unrestricted choice of targets, minimal side effects and costeffectiveness compared to protein therapies. However, this technology has its own limitations. To overcome its drawbacks, an effective drug delivery system is needed to deliver the administered therapeutic to its intended site. In this study, cross-linked nanolipogel (NLG) particles containing Chitosan Methacrylate Anhydride (Chitosan-MA) and SPARC small interfering RNA (siRNA) were designed and fabricated in the effort to prolong the administered therapy. The formulated NLG particles were characterised and found to be spherical with diameter of 139.6 ± 0.76 nm. Following that, siRNA release study was conducted on the NLG over 28 days. From the release study, it was observed that the cross-linked NLG particle could sustain release siRNA over 28 days. The remaining SPARC siRNA within the NLG suggested potential release profile to be more than 28 days. A 14-day cell toxicity study conducted showed 0.03125mM NLG to be the suitable dosage for subsequent in vitro studies. Qualitative and quantitative cell studies conducted to observe NLG entry into Human FibroGRO fibroblast cells showed 20 % cell entry after 1-day of NLG treatment. This study validated that the NLG system developed could not only efficiently encapsulate siRNA, but also sustains release siRNA over 28 days without drastically hindering cell proliferation.
author2 Subbu S. Venkatraman
author_facet Subbu S. Venkatraman
Muhammad Aminuddin Anuar
format Final Year Project
author Muhammad Aminuddin Anuar
author_sort Muhammad Aminuddin Anuar
title Cell-mimicking nanolipogel for encapsulation & delivery of SPARC siRNA
title_short Cell-mimicking nanolipogel for encapsulation & delivery of SPARC siRNA
title_full Cell-mimicking nanolipogel for encapsulation & delivery of SPARC siRNA
title_fullStr Cell-mimicking nanolipogel for encapsulation & delivery of SPARC siRNA
title_full_unstemmed Cell-mimicking nanolipogel for encapsulation & delivery of SPARC siRNA
title_sort cell-mimicking nanolipogel for encapsulation & delivery of sparc sirna
publishDate 2019
url http://hdl.handle.net/10356/76737
_version_ 1759856731999961088